Human Coagulation Factor VIII

About Hualan Biological Engineering

Hualan Biological Engineering's mission is to safeguard public health through the research, development, and large-scale manufacturing of high-quality vaccines and plasma-based therapeutics. The company has achieved a leading market share in China's influenza vaccine segment and built a formidable, asset-heavy business model anchored by its extensive plasma station network and established manufacturing platforms. Its strategy focuses on defending its core franchises while strategically investing in next-generation vaccine technologies, including cell culture-based production and conjugate vaccines, to drive future growth and enhance pandemic preparedness.

Therapeutic Areas

Other Hemophilia A Drugs